Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
NCT ID: NCT02251574
Last Updated: 2018-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2014-09-30
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of CPAP on Diet, Physical Activity, and Cardiovascular Risk
NCT01944020
Nutritional Rehabilitation and Sleep Apnea in the Obese
NCT03857191
Influence of Exercise, Weight Loss, and Exercise Plus Weight Loss on Sleep Apnea
NCT02721251
Comparison of Physical Activity Regimens as Treatments for Obstructive Sleep Apnea
NCT00956423
Lifestyle Intervention in Obstructive Sleep Apnoea
NCT01546792
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Although anyone can develop OSA, it commonly affects people who are obese. The more someone weighs, the more likely the OSA is to be severe. Weight loss is typically recommended for overweight individuals to help improve OSA. However, not enough research has been done for doctors to be able make specific recommendations to their patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Calorie Diet
Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 1200-1500 calories per day.
Low Calorie Diet
Weight management program designed around a low calorie diet.
Very Low Calorie Diet
Participants will take part in an experimental weight management program involving a low calorie diet (LCD), about 520-800 calories per day.
Very Low Calorie Diet
Weight management program designed around a very low calorie diet.
Standard Care
Participants will receive normal care.
Standard Care
Care provided that would normally be given to people meeting eligibility criteria for this study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Calorie Diet
Weight management program designed around a low calorie diet.
Very Low Calorie Diet
Weight management program designed around a very low calorie diet.
Standard Care
Care provided that would normally be given to people meeting eligibility criteria for this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index (BMI) between 30 to 49.9 kg/m2
Exclusion Criteria
* Currently or planning to become pregnant during the next 9 months
* Not weight stable (-4.6 kg) for 3 mos. prior to intake
* Report current participation in a weight reduction program involving diet or PA
* Unwilling to be randomized to 1 of 3 study groups
* Report symptomology of an eating disorder as determined by the Eating Attitudes Test
* Unable to participate in moderate intensity physical activity
21 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeannine Goetz, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kansas Medical Center
Kansas City, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00001418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.